Tactic Pharma LLC - 28 Jan 2026 SCHEDULE 13D/A Report for Monopar Therapeutics Common Stock, $0.001 par value (MNPR)

Filing Manager
Tactic Pharma LLC
Reporting Manager
Tactic Pharma LLC
Security
Monopar Therapeutics Common Stock, $0.001 par value
Symbol
MNPR
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13D/A
Filing time
30 Jan 2026, 14:32:27 UTC
Date of event
28 Jan 2026
Previous filing
24 Sep 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Tactic Pharma LLC 0% 0 0 0 /s/ Chandler Robinson Chandler Robinson 0001727357
Robinson Chandler 4.5% 307,370 307,370 0 /s/ Chandler Robinson Chandler Robinson 0001727334
Brown Michael J 1.8% 124,629 124,629 0 /s/ Michael Brown Michael Brown 0001035909